Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus

Impaired health-related quality of life (HRQoL) is a major problem in patients with systemic lupus erythematosus (SLE). Antimalarial agents (AMA) are the cornerstone of SLE therapy, but data on their impact on HRQoL are scarce. We investigated this impact using baseline data from the BLISS-52 (NCT00...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez, Alvaro, Soukka, Sofia, Johansson, Petter, Åkerström, Emil, Emamikia, Sharzad, Enman, Yvonne, Chatzidionysiou, Katerina, Parodis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355692/
https://www.ncbi.nlm.nih.gov/pubmed/32532059
http://dx.doi.org/10.3390/jcm9061813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355692/
https://www.ncbi.nlm.nih.gov/pubmed/32532059
http://dx.doi.org/10.3390/jcm9061813

Ejemplares similares